ストックスクリーナーアプリを入手
80.31
0.19%
0.0317
Lemaitre Vascular Inc (LMAT) 最新ニュース
Summit Creek Advisors LLC Buys New Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Bank of America Corp DE Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Rice Hall James & Associates LLC Purchases Shares of 189,907 LeMaitre Vascular, Inc. $LMAT - MarketBeat
LMAT Q2 2026 Earnings: EPS Misses Estimates as Stock Holds Modest DeclinePre-Earnings Setup - vinanet.vn
LeMaitre Vascular (LMAT) Edges Higher to $82.38, Holding Ground Above Key SupportMean Reversion Trade - vinanet.vn
LeMaitre Vascular (LMAT) Advances Modestly to $82.38 as Range-Bound Trading PersistsDaily Profile - dars.gov.et
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular (LMAT) Holds Steady Near $82 as Medtech Sector Shows ResilienceVolume Nodes - Vinanet
How Investors May Respond To LeMaitre Vascular (LMAT) Trimmed 2026 Outlook Despite Higher Q2 Sales - simplywall.st
Price performance - Yahoo Finance Australia
LeMaitre Vascular remains a Buy despite 31% pul... - Pluang
LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT) - Seeking Alpha
The Technical Signals Behind (LMAT) That Institutions Follow - Stock Traders Daily
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 39% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call - The Globe and Mail
Quantinno Capital Management LP Buys 18,204 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Has A Fresh Update, So Why Is It Drawing Attention? - Sahm
31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update - Yahoo Finance
LeMaitre Vascular, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - simplywall.st
LeMaitre Vascular (LMAT) Hit by Profit Taking - AlphaStreet
LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - The Manila Times
LeMaitre management to meet investors at virtual Aug. 11 event - Stock Titan
LeMaitre Vascular sales increase 10% to USD 70.4M in Q2 2026 - Medical Buyer
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo Finance
Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95 - Yahoo Finance
Stocks making big moves yesterday: LeMaitre, ePlus, Booking, Paymentus, and Vishay Intertechnology - theglobeandmail.com
LMAT SWOT Analysis: Strong Financial Growth and Market Position Revealed in 10-Q Filing - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year Low on Analyst Downgrade - MarketBeat
LeMaitre Vascular stock hits 52-week low at 79.38 USD By Investing.com - Investing.com Nigeria
LeMaitre Vascular stock hits 52-week low at 79.38 USD - Investing.com
LeMaitre Vascular Down Over 22%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk - Moomoo
LMAT Looks 15.2% Undervalued on GF Value™ Despite Recent Sharp P - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Price Target Cut to $94.00 by Analysts at Wells Fargo & Company - MarketBeat
Why LeMaitre (LMAT) Shares Are Getting Obliterated Today - TradingView
Why is LeMaitre Vascular stock tumbling today? By Investing.com - Investing.com South Africa
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down on Disappointing Earnings - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research - MarketBeat
LeMaitre Vascular, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform - Yahoo Finance
Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside - TradingView
LeMaitre Vascular Announces Q2 2026 Earnings with Increased Sales and Net Income - Kalkine Media
LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ... - Yahoo Finance
LEMAITRE VASCULAR, INC. : BARRINGTON RESEARCH CUTS TO MARKET PERFORM FROM OUTPERFORM - Bitget
LeMaitre Vascular Q2 Earnings Call Highlights - MarketBeat
Is LeMaitre Vascular Inc (LMAT) Overvalued After Q2 Earnings Mis - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results - marketbeat.com
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates - finance.yahoo.com
LeMaitre Vascular (NASDAQ:LMAT) Releases Q4 2026 Earnings Guidance - MarketBeat
Earnings call transcript: LeMaitre Vascular slips on Q2 2026 miss, cuts outlook - Investing.com
GUIDANCE: (LMAT) LeMaitre Vascular Expects Full Year 2026 EPS Range $2.84$2.94, Vs. FactSet Est of $3.00 - Moomoo
LeMaitre Vascular Inc reports results for the quarter ended June 30Earnings Summary - TradingView
LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6% - Yahoo Finance
Q2 2026 LeMaitre Vascular Inc Earnings Call Transcript - GuruFocus
LeMaitre Vascular (NASDAQ:LMAT) Updates FY 2026 Earnings Guidance - MarketBeat
LeMaitre Q2 2026 sales rise 10 percent to $70.4 million - Quiver Quantitative
LeMaitre: Q2 Earnings Snapshot - KHOU
LeMaitre Vascular Q2 sales slightly miss estimates - TradingView
LeMaitre Q2 2026 Financial Results - The Manila Times
BRIEF-LeMaitre Vascular Q2 Sales USD 70.382 Million Vs. IBES Estimate USD 71 Million - TradingView
LeMaitre says Artegraft is now approved in 56 countries - stocktitan.net
0.76%
1.23%
大文字化:
|
ボリューム (24 時間):